Articles from Biotech Financial Reports (September 1, 2001)

Title	Author	Type	Words
ABGENIX REPORTS NET LOSS OF $14.8 MILLION FOR 2ND QTR.		Brief Article	436
CELL PATHWAYS REPORTS DECREASED NET LOSS FOR SECOND QTR.		Brief Article	713
CEPHEID REPORTS NET LOSS OF $4.1 MILLION FOR 2ND QTR.		Statistical Data Included	1300
CERUS REPORTS INCREASED NET LOSS FOR SECOND QTR.		Brief Article	413
DIACRIN REPORTS 2ND QTR NET LOSS OF $1.3 MILLION.		Brief Article	292